MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.
about
Human Anti-Oxidation Protein A1M--A Potential Kidney Protection Agent in Peptide Receptor Radionuclide TherapyOptimizing CIGB-300 intralesional delivery in locally advanced cervical cancer.Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activityEstimation of Organ Absorbed Doses in Patients from (99m)Tc-diphosphonate Using the Data of MIRDose Software.Whole body MR-PET: a new internal dosimetry method for radiation transport calculation from biokinetic model data.Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.Dosimetry for radiopharmaceutical therapyMonte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PETFirst in-human radiation dosimetry of 68Ga-NODAGA-RGDyKLu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and DosimetryEffects of shortened acquisition time on accuracy and precision of quantitative estimates of organ activity.Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan.Image quantification for radiation dose calculations--limitations and uncertaintiesTandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma.A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety.Beyond Palliation: Therapeutic Applications of 153Samarium-EDTMP.Activity estimation in radioimmunotherapy using magnetic nanoparticles.Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a reviewClinical radionuclide therapy dosimetry: the quest for the "Holy Gray".In vivo quantification of (177)Lu with planar whole-body and SPECT/CT gamma camera imagingInvestigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting Peptides.Time to demand dosimetry for molecular radiotherapy?Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapyPlatelet binding and biodistribution of [99mTc]rBitistatin in animal species and humansEstimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocolGlucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.Comparison of Accuracy in Calculation of Absorbed Dose to Patients Following Bone Scan with (99m)Tc-Marked Diphosphonates by Two Different Background Correction MethodsDependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling scheduleThe joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursComparison of residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--Monte Carlo simulation studies.IMPROVED PLANAR KIDNEY ACTIVITY CONCENTRATION ESTIMATE BY THE POSTERIOR VIEW METHOD IN 177LU-DOTATATE TREATMENTS.In Vivo Measurement and Characterization of a Novel Formulation of [177Lu]-DOTA-Octreotate.A novel planar image-based method for bone marrow dosimetry in (177)Lu-DOTATATE treatment correlates with haematological toxicityRadiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancerMIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.Estimation of Organ Activity using Four Different Methods of Background Correction in Conjugate View Method.Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT systemA 3D Monte Carlo Method for Estimation of Patient-specific Internal Organs Absorbed Dose for (99m)Tc-hynic-Tyr(3)-octreotide Imaging.
P2860
Q26773377-E5AFFBE9-EFC9-4997-8793-19F49D9E5195Q27332192-D6DF1BDC-FA92-49F2-86E7-1D8768D777A8Q30561088-2D38D55D-6BA9-4D21-A1E1-F9F8D20E3DE7Q30637334-CD5C66BF-3AAA-4D02-89CB-3681677D77EAQ31011183-21A5B50F-BEB7-46FB-8ACA-60DEAEE60DDEQ33383964-F84BCB86-2F6F-4962-8548-651A754C0530Q33665116-DFD87228-33B7-4E91-97F4-33E1FEA7C809Q33682852-87080884-6D70-4D9A-B35A-8D10F78136EBQ33704623-9C42AEA4-E908-4AD9-92DE-09AB4D6FB774Q33802694-3B78C93F-101F-4A0A-A55F-E312AA9283F2Q33830177-4E6F4401-2EBB-4785-BDA2-3B956867B5CBQ34117144-374763CF-B44B-4E2B-ADA4-4998E64B9215Q34196584-B0B198CC-21E2-46B0-966F-C86F17CFCCD7Q34348226-92AB080B-8613-42AD-8F3B-91F259D05F08Q34523934-97981198-7186-4766-9FAD-04B727FF1437Q35057029-AB575494-ABC0-4D43-8490-207C9E3A1148Q35538763-65B54F0D-8A60-4041-A888-935ABFB55196Q35556123-9EA30E2F-536D-4866-AEC1-82F19AE4A843Q35880923-51186218-09F9-4783-A878-D05A52AAFC65Q36069826-26F9B2F8-C99A-4080-AF7D-61BA561049F2Q36128368-1C35EC8D-9E2B-44F9-8249-179D728BF57EQ36295237-B206A384-5BF2-480A-BFC5-D8A3B51320DFQ36297804-DFDD6F4B-300B-4B09-A513-B335D9B936C7Q36300599-12466114-869D-41BC-B601-63AE0C1AA47DQ36302205-E4EB7F2F-6120-4767-95E8-B2BE66828B4BQ36482132-EC95F2A5-5721-44E4-89C0-19954A5E5F83Q36639160-AFDEA3CC-3B08-4A7E-BCCB-1C0BF80E5DE0Q36662850-F835A167-6189-4D3D-AEA4-B2C590D79D39Q36675430-54A2806B-8329-4BA9-8E09-88780F83B623Q36729683-BA4FF1B6-2769-4EBC-B033-61A0B604A6D7Q36755905-EAD0AEF4-0631-4FA4-8914-4A47131EF12CQ36987158-74655EF0-8DB2-457F-935D-8564FB570244Q37016021-BBE25026-FCED-45FD-8795-BE6244DE4FB4Q37077269-81EFBA28-DB33-4594-8D82-284B6A543134Q37273187-E553D68A-1ED8-45E8-8098-0D3DF5063E88Q37378234-41307041-692A-439D-B6EA-E1EF1E0FF3D9Q37676716-0D0166B1-A1A2-42C5-B836-5C047ED728A3Q38559340-3F4F1155-C50E-45E6-A32A-EE7323B7116AQ38898323-3A2FBA23-8F04-4F22-AF44-7357EF24DDE9Q39550058-CE533092-6281-4A8C-A855-580597CFB0AA
P2860
MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
MIRD pamphlet no. 16: Techniqu ...... uman radiation dose estimates.
@ast
MIRD pamphlet no. 16: Techniqu ...... uman radiation dose estimates.
@en
type
label
MIRD pamphlet no. 16: Techniqu ...... uman radiation dose estimates.
@ast
MIRD pamphlet no. 16: Techniqu ...... uman radiation dose estimates.
@en
prefLabel
MIRD pamphlet no. 16: Techniqu ...... uman radiation dose estimates.
@ast
MIRD pamphlet no. 16: Techniqu ...... uman radiation dose estimates.
@en
P2093
P1476
MIRD pamphlet no. 16: Techniqu ...... uman radiation dose estimates.
@en
P2093
Robertson JS
P304
P407
P577
1999-02-01T00:00:00Z